Pharmaceutical Microbiology Manual
Download 1.15 Mb. Pdf ko'rish
|
ORA.007 Pharmaceutical Microbiology Manual
- Bu sahifa navigatsiya:
- Revised: 25 Aug 2020 Title: Pharmaceutical Microbiology Manual
F
OOD AND D RUG A DMINISTRATION O FFICE OF R EGULATORY A FFAIRS Office of Regulatory Science Document Number: ORA.007 Revision #: 02 Revised: 25 Aug 2020 Title: Pharmaceutical Microbiology Manual Page 10 of 92 For the most current and official copy, check QMiS. When conducting the testing, the analyst should wear a clean lab coat, sterile sleeves and sterile gloves. Gloves should be frequently disinfected especially between opening and handling sample (product) units. Depending on the type of Laminar Flow Hood or equipment barriers in a particular laboratory, it might be beneficial to also wear a surgical mask and hair net. C. Growth Promotion, Indicative and Inhibitory Properties of the Media Test each batch of ready-prepared medium and each batch of medium prepared either from dehydrated medium or from ingredients for growth promotion and where appropriate, for indicative and inhibitory properties, following USP <60>, <61> and <62>. Each chapter provides guidance on test strains to be used for each type of media, refer to Table 1 of USP <60>, <61> and <62>. Ensure that seed-lot cultures used are not more than five passages removed from the original master seed-lot. Test strains suspensions should be used within 2 hours, or within 24 hours if refrigerated between 2ºC and 8ºC. Spore suspensions (A. brasiliensis, B. subtilis, and C. sporogenes) refrigerated between 2ºC and 8ºC may be kept for a validated period. If commercially available ready-to-use bacteria or fungal suspension are used, then the manufacturer’s instructions should be followed with respect to preparation and storage requirements. Additionally, all bacterial and spore suspensions should be prepared to yield ≤100 CFU. Growth promotion (and suitability test) plates and tubes should not be incubated in the same incubators used for product testing. If this cannot be avoided because of limited space, it is preferable to store the “spiked samples” in the lower half of the incubator below the sample inoculated plates and tubes. D. Suitability of the Test Method Suitability demonstrates that the products tested do not exhibit inhibitory effects on the growth of microorganisms under the conditions of the tests. Although the intent is to perform the suitability test before performing the analysis of the product, it is acceptable to run the product test and the suitability test concurrently. However, it should be noted that if the suitability test is run concurrently with the product test and the suitability test should fail, the results of the product test are invalid and the suitability test as well as the product test will need to be repeated with proper method modification to neutralize the inhibiting property. Neutralizing agents may be used to neutralize the activity of antimicrobial agents in products, see USP <61> Table 2 for a list of potential neutralizing agents/methods. The appropriate neutralizing agent should be added preferably before sterilization of the media. Include a blank control with neutralizer and without product to demonstrate efficacy and absence of toxicity for microorganisms. |
Ma'lumotlar bazasi mualliflik huquqi bilan himoyalangan ©fayllar.org 2024
ma'muriyatiga murojaat qiling
ma'muriyatiga murojaat qiling